September 18, 2025

Psoriasis Linked to Macular Degeneration

 Vision-threatening eye disease more common in psoriasis patients, but biologic therapy appears protective.

Conexiant

September 15, 2025

ARCHER Study Supports at Least 15-Letter Loss as Meaningful Endpoint in Dry AMD With GA

Phase 2 results show vonaprument reduced the risk of significant visual decline compared with sham.

Retinal Physician

June 02, 2025

Geographic Atrophy: Early Detection and Patient Awareness Matters

Learn about the essential steps optometrists can take to support patients with geographic atrophy and preserve vision.

Optometric Management

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

May 15, 2025

Periodontitis Emerges as Modifiable Risk Factor for AMD

Inflammatory mediators are shared between the conditions.

Conexiant

February 13, 2025

FDA Approves Extended Label for Avacincaptad Pegol

The new label removes limitations on the duration of dosing.

Conexiant

August 01, 2023

E-insights Into the Latest in Patient Care and Practice Management

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management